Effect of FAS and FAS Ligand Polymorphisms on Patients With Platinum-Based -Treated Malignant Pleural Mesothelioma
NCT02269878 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 68
Last updated 2018-01-03
Summary
To Study the Effect of Polymorphisms in Fas Ligand Gene Promoter Region (rs 763110) and Fas gene (rs1800682) on Platinum-Based regimens used in treatment of malignant pleural mesothelioma (MPM)
Conditions
- Malignant Pleural Mesothelioma
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-04-30
- Primary Completion
- 2016-06-30
- Completion
- 2016-12-31
Countries
- Egypt
Study Locations
More Related Trials
-
IP3R Modulation by Cancer Genes in Mesothelioma
NCT03558932 ·Status: UNKNOWN
-
Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients
NCT02300883 ·Status: COMPLETED
-
Mesothelioma Early Detection by VOCs
NCT04106973 ·Status: TERMINATED
-
Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite
NCT00897247 ·Status: COMPLETED
-
Correlation Between Tissue and Plasmatic EGFR in CBNPC With EGFR Mutation or Predictive Factor of EGFR Mutation
NCT03265496 ·Status: TERMINATED ·Phase: NA
-
Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes
NCT03830229 ·Status: RECRUITING
-
Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
NCT00991991 ·Status: TERMINATED
-
Identification and Characterization of Molecular Markers in Musculoskeletal Tumors
NCT02199938 ·Status: TERMINATED
-
Molecular Profiling and Molecular Labeling of Inflammatory Myofibroblastic Tumor
NCT04572594 ·Status: UNKNOWN
-
Microarray Analysis of microRNA Expression in Basal Cell Carcinoma
NCT01498250 ·Status: COMPLETED
-
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs
NCT05782985 ·Status: UNKNOWN
-
Use of Exome Sequence Analysis and Circulating Tumour in Assessing Tumour Heterogeneity in BRAF Mutant Melanoma
NCT02251314 ·Status: COMPLETED
-
Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS
NCT06559033 ·Status: NOT_YET_RECRUITING
-
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
NCT01950572 ·Status: RECRUITING
-
P53 Immunohistochemistry Abnormal Staining in Endometrial Cancer
NCT05542940 ·Status: COMPLETED
-
DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer
NCT00339859 ·Status: COMPLETED
-
Treatment of Multifocal Lung Adenocarcinoma
NCT01946100 ·Status: TERMINATED ·Phase: NA
-
A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer
NCT01919749 ·Status: COMPLETED ·Phase: NA
-
BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer
NCT02458664 ·Status: UNKNOWN
-
MucinB5 Gene Polymorphism and Leucocytes Telomere Length in Interstitial Lung Diseases
NCT06498141 ·Status: RECRUITING
-
Genomic Analysis of Peritoneal Mesothelioma by CGH Arrays
NCT02834234 ·Status: COMPLETED
-
A Gene Hunting Study for Familial Papillary Thyroid Cancer
NCT02776969 ·Status: ACTIVE_NOT_RECRUITING
-
The Role of Genetic Mutations and of Circulating mRNAs in Uveal Melanoma
NCT05179174 ·Status: UNKNOWN
-
Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients
NCT00213798 ·Status: COMPLETED ·Phase: NA
-
Validation of a Molecular Prognostic Test for Eye Melanoma
NCT00406120 ·Status: WITHDRAWN